State-Of-The-Art ZLB Behring Plant Licensed By The FDA
KANKAKEE, Ill.--(BUSINESS WIRE)--April 18, 2006--ZLB Behring today announced that it has been granted a license by the U.S. Food and Drug Administration (FDA) to produce Alpha-1 Proteinase Inhibitor (Human), Zemaira®, in a new facility in its Kankakee, Illinois, manufacturing complex.